9.3 C
New York
Sunday, May 9, 2021

RCKT

- Advertisement -

Rocket Pharmaceuticals (RCKT) Touches 5-Year High on Positive Gene Expression; Also, Prices Upsized Common Stock Offering

Rocket Pharmaceuticals reports promising Phase 1 data from its gene therapy in heart disease.RCKT shares skyrocketed, reaching a five-year high of $63.94.The pharmaceutical firm...
- Advertisement -

Must Read

- Advertisement -